52w high/low | ₹259.7 / ₹102.5 |
P/E ratio | 0 |
Dividend | 0 |
ROE | -1.89 |
ROCE | -0.73 |
Face value | 2 |
Book value | ₹258.48Cr |
Market capital | ₹2,863.64Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Dishman Carbogen Amcis Limited was incorporated in the year July 17, 2007. The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. As on 31st March 2019, the total number of subsidiaries including step down subsidiaries were 14. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure. The name of Carbogen Amcis (India) Ltd. was changed to Dishman Carbogen Amcis Ltd. with effect from 27 March 2017.